SCHEMBL29445936

SCHEMBL29445936

CCOc1ccsc1C(=O)NCCO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.61
HCRTR1 O43613 2/20 0.47
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 4/20 0.44
CYP1A2 P05177 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
NAMPT P43490 1/20 0.41
GAA P10253 1/20 0.41
MMP13 P45452 1/20 0.41
MAPK1 P28482 2/20 0.41
ALOX15 P16050 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360976 0.90 KMT2A (0.63) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL29445950 0.87 KMT2A (0.64) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL22408180 0.86 KMT2A (0.67) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL6655913 0.81 KMT2A (0.69) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL22408118 0.81 KMT2A (0.69) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL6239505 0.79 ALDH1A1 (0.47) KMT2AALDH1A1MEN1CYP1A2L3MBTL1
SCHEMBL22408141 0.79 KMT2A (0.65) KMT2AALDH1A1MEN1CYP1A2L3MBTL1
SCHEMBL22408109 0.78 KMT2A (0.60) KMT2AHCRTR1ALDH1A1MEN1CYP1A2
SCHEMBL21939832 0.77 KMT2A (0.61) KMT2AALDH1A1MEN1CYP1A2L3MBTL1
SCHEMBL22067788 0.77 KMT2A (0.61) KMT2AALDH1A1MEN1CYP1A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12011444-B2 N-substituted indole derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-18 US disclosed
US-20220175775-A1 N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2022-06-09 US disclosed
US-11241431-B2 N-substituted indole derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2022-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175775-A1 N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS PTGER1, PTGER4, PTGER2 KMT2A 2262/4885HCRTR1 670/4885ALDH1A1 761/4885
US-12011444-B2 N-substituted indole derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 KMT2A 2262/4885HCRTR1 670/4885ALDH1A1 761/4885
US-11241431-B2 N-substituted indole derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 KMT2A 2262/4885HCRTR1 670/4885ALDH1A1 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.